Exhibit 23.1
                                                                    -------

                         INDEPENDENT AUDITORS' CONSENT

The Board of Directors
Unigene Laboratories, Inc.:

     We consent to the use of our report included herein and to the reference
to our firm under the headings "Selected Financial Data" and "Experts" in the
prospectus. Our report dated March 30, 2001 contains an explanatory paragraph
that states that Unigene Laboratories, Inc. has suffered recurring losses from
operations and has a working capital deficiency which raise substantial doubt
about its ability continue as a going concern. The financial statements do not
include any adjustments that might result from the outcome of that uncertainty.
Also, our report refers to a change in the method of accounting for revenue
recognition for up-front non-refundable license fees in 2000.

/s/KPMG LLP
- --------------
KPMG LLP

Short Hills, New Jersey

February 11, 2002